2017
DOI: 10.1128/jcm.01215-17
|View full text |Cite
|
Sign up to set email alerts
|

High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases

Abstract: There is an urgent need for rapid, accurate detection and classification of carbapenemases. The current study evaluated the automated BD Phoenix CPO Detect and the manual bioMérieux Rapidec Carba NP tests for meeting these needs. Both tests were challenged with 294 isolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacter baumannii chosen to provide extreme diagnostic difficulty. Carbapenemases such as KPC, NMC-A, IMI, SME, NDM, SPM, IMP, VIM, and OXA-23, 40, 48, 58, 72, 181, and 232 were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

8
24
2
3

Year Published

2018
2018
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(40 citation statements)
references
References 28 publications
8
24
2
3
Order By: Relevance
“…Becton-Dickinson (BD, Sparks, USA) recently developed the Phoenix CPO Detect Test, a growth-based method embedded in Gram-negative (GN) panels for the detection and confirmation of carbapenemases of classes A, B and D [21]. This study aimed to determine the performance of the CPO test and to investigate its added value in routine diagnostic workflows.…”
Section: Introductionmentioning
confidence: 99%
“…Becton-Dickinson (BD, Sparks, USA) recently developed the Phoenix CPO Detect Test, a growth-based method embedded in Gram-negative (GN) panels for the detection and confirmation of carbapenemases of classes A, B and D [21]. This study aimed to determine the performance of the CPO test and to investigate its added value in routine diagnostic workflows.…”
Section: Introductionmentioning
confidence: 99%
“…The rapid spread of CPE, including those with MBLs, has become a critical challenge of infection control and treatment [8]. The first carbapenemaseproducing bacteria were identified in 1991 in Japan [9]. Since then, these beta-lactamases have spread worldwide among Gram-negative bacteria, especially K. pneumoniae strains.…”
Section: Discussionmentioning
confidence: 99%
“…The BD Phoenix CPO Detect is an automated system applying dedicated panels to detect and classify carbapenemases [9]. Using these panels, Thomson [23].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Identification of class A carbapenemases indicates that the currently FDA-approved agents, ceftazidime/avibactam and meropenem/vaborbactam, are potential therapeutic options, while the detection of a class B carbapenemase contraindicates these agents. Classification can be a clinically powerful source of information about whether or not these agents are contenders for therapy but it does not eliminate the need for antibiotic susceptibility testing (15).…”
Section: Discussionmentioning
confidence: 99%